Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/11/882
Active ingredient: Fresolimumab
Indication: Treatment of focal segmental glomerulosclerosis
Sponsor: Genzyme Europe B.V.
Gooimeer 10, 1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/08/2011 Orphan designation EMA/OD/146/10 (2011)5807 of 05/08/2011
31/07/2015 Removal of orphan designation from Community Register